As a relatively new entrant in the healthcare sector, Fortrea Holdings Inc. (NASDAQ: FTRE) is making waves in the biotechnology industry. Incorporated in 2023 and headquartered in Durham, North Carolina, Fortrea offers a wide range of clinical services, focusing on biopharmaceutical product and medical device development. Despite being a newcomer, the company has already garnered attention with its strategic collaborations and comprehensive service offerings.

**Current Market Position**

With a market capitalization of $948.95 million, Fortrea is a noteworthy player in the biotech space. The company’s current stock price stands at $10.27, having experienced a slight decline of 0.11% recently. However, the stock’s 52-week range,…